While touted as a virtual end to Vioxx litigation, the recent $4.85 billion settlement struck by Merck & Co. Inc. to resolve products liability claims does not get the pharmaceutical giant out of the woods.

In reality, a number of lawsuits are still pending against Merck in both state and federal courts around the country.